Clinical Trials Directory

Trials / Completed

CompletedNCT00651196

Bone Health in Type 1 Diabetes

Pilot Study - Type 1 Diabetes and Bone Health

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Creighton University · Academic / Other
Sex
All
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

An increased skeletal fracture risk in diabetes has only recently been recognized. This human study is designed to elucidate the effect of Type 1 diabetes on bone remodeling and on structure.

Detailed description

An increased skeletal fracture risk in diabetes has only recently been recognized. Human studies of patients with diabetes using bone mineral density and bone markers have noted low bone mass and mixed results on remodeling activity. Mouse models of diabetes have suggested that low bone turnover is the underlying problem. Low bone turnover could lead to an accumulation of microdamage that is not repaired causing compromised bone strength. Low bone turnover has not yet been confirmed in humans. This human study is designed to elucidate the effect of Type 1 diabetes on 1) bone remodeling, including histomorphometric and biochemical measures of bone formation and resorption, and 2) on structure, including micro architectural arrangement of trabeculae and bone mineral density.

Conditions

Timeline

Start date
2008-01-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2008-04-02
Last updated
2013-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00651196. Inclusion in this directory is not an endorsement.

Bone Health in Type 1 Diabetes (NCT00651196) · Clinical Trials Directory